A $100K pre-seed check has landed at Powerhouse Therapeutics, a biotech startup spun out of UT Health San Antonio. The round marks early backing for a company aiming to move academic science into the clinic.
Powerhouse is developing a first-in-class cell-based therapy for solid tumors, designed to hit multiple resistance pathways at once. The scientists behind it are focused on translating their lab work into biologic treatments for patients, though specifics on how the fresh capital will be deployed weren't disclosed.
